PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

Mariam Ben Kacem(The University of Texas MD Anderson Cancer Center), Gabriel O. Sawakuchi(The University of Texas MD Anderson Cancer Center)
Scientific Reports
December 28, 2024
Cited by 5


Related Papers